Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation

Journal of Medicinal Chemistry

Volumn 42, Issue 22, 1999, Pages 4669-4679

  Jung, Manfred ^a   Brosch, Gerald ^b   Kölle, Doris ^b   Scherf, Hans ^c   Gerhäuser, Clarissa ^c   Loidl, Peter ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; TRAPOXIN B; TRICHOSTATIN A; TRICHOSTATIN A DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL DIFFERENTIATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME INHIBITION; IN VITRO STUDY; MOUSE; NONHUMAN; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION;

EID: 0033523895     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm991091h     Document Type: Article

References (28)

1. Loidl, P. Histone acetylation: facts and questions. Chromosoma 1894, 103, 441-449.
2. There are various acronyms for histone deacetylase, such as HD, HDA, or HDAC. Although the latter two have been favored lately, there is still no official version. We prefer HD as the maize enzyme used in this study is definitely termed HD-2, and we wanted to avoid two acronyms for the same term.
3. Pennisi, E. Opening the way to gene activity. Science 1997, 275, 155-157.
4. Pazin, M. J.; Kadanoga, J. T. What's up and down with histone deacetylation and transcription? Cell 1997, 86, 325-328.
5. Lusser, A.; Brosch, G.; Loidl, A.; Haas, H.; Loidl, P. Identification of maize histone deacetylase HD 2 as an acidic nucleolar phosphoprotein. Science 1997, 277, 88-91.
6. Liu, R. J.; Nagy, L.; Inoue, S.; Shao, W.; Miller, V. H.; Evans, R. M. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 1998, 391, 811-814.
7. Grignani, F.; De Matteis, S.; Nervi, C.; Tomassoni, L.; Gelmetti, V.; Cioce, M.; Fanelli, M.; Ruthardt, M.; Ferrara, F. F.; Zamir, I.; Seiser, C.; Grignani, F.; Lazar, M. A.; Minucci, S.; Pelicci, P. G. Fusion proteins of the retinoic acid receptor-A recruit histone deacetylase in promyelocytic leukaemia. Nature 1998, 391, 815-818.
8. Borrow, J.; Stanton Jr., V. P.; Andresen, J. M.; Becher, R.; Behm, F. G.; Chaganti, R. S.; Civin, C. I.; Disteche, C.; Dube, I.; Frischauf, A. M.; Horsman, D.; Mitelman, F.; Volinia, S.; Watmore, A. E.; Housman, D. E. The translocation t(8;16)-(p11;p13) of acute myeloid leukaemia fuses a putative histone acetyltransferase to the CREB-binding protein. Nature Genet. 1996, 14, 33-41.
9. Siddique, H.; Zou, J.-P.; Rao, V. N.; Reddy, E. S. P. The BRCA2 is a histone acetyltransferase. Oncogene 1998, 16, 2283-2285.
10. Jung, M.; Hoffmann, K.; Brosch, G.; Loidl, P. Analogues of trichostatin A and trapoxin B as histone deacetylase inhibitors. Bioorg. Med. Chem. Lett. 1997, 7, 1655-1658.
11. Hoshika, Y.; Kwon, H. J.; Yoshida, M.; Horinouchi, S.; Beppu, T.; Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines. Exp. Cell Res. 1994, 214, 431-437.
12. Saito, A.; Yamashita, T.; Manko, Y.; Nosaka, Y.; Tsuchiya, K.; Ando, T.; Suzuki, T.; Tsuruo, T.; Nakanishi, O. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 4592-4597.
13. Suzuki, T.; Ando, T.; Tsuchiya, K.; Fukazawa, N.; Saito, A.; Manko, Y.; Yamashita, T.; Nakanishi, O. Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives. J. Med. Chem. 1999, 42, 3001-3003.
14. Brosch, G.; Lusser, A.; Goralik-Schramel, M.; Loidl, P. Purification and characterization of a high molecular weight histone deacetylase complex (HD2) of maize embryos. Biochemistry 1996, 35, 15907-15914.
15. Yoshida, M.; Kijima, M.; Akita, M.; Beppu, T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem 1990, 265, 17174-17179.
16. Richon, V. M.; Emiliani, S.; Verdin, E.; Webb, Y.; Breslow, R.; Rifkind, R. A.; Marks, P. A. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 3003-3007.
17. Kölle, D.; Brosch, G.; Lechner, T.; Lusser, A.; Loidl, P. Biochemical methods for analysis of histone deacetylases. Methods 1998, 15, 323-331.
18. Alfageme, C. R.; Zweidler, A.; Mahowald, L. H.; Cohen, L. H. Histones of Drosophila embryos. Electrophoretic isolation and structural studies. J. Biol. Chem. 1974, 249, 3729-3736.
19. He, L. Z.; Guidez, F.; Triboli, C.; Peruzzi, D.; Ruthardt, M.; Zelent, M.; Pandolfi, P. P. Distinct interactions of PML-RARal-pha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL. Nature Genet. 1998, 18, 126-135.
20. Lea, M. A.; Tulsyan, N. Discordant effects of butyrate analogues on erythroleukemia cell proliferation, differentiation and histone deacetylase. Anticancer Res. 1995, 15, 879-884.
21. Warrell Jr., R. P.; He, L.-Z.; Richon, V.; Calleja, E.; Pandolfi, P. P. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J. Natl. Cancer Inst. 1999, 90, 1621-1625.
22. Hagmann, W. K.; Lark, M. W.; Becker, J. W. Inhibition of matrix metalloproteinases. Annu. Rep. Med. Chem. 1996, 31, 231-240.
23. Hoffmann, K.; Brosch, G.; Loidl, P.; Jung, M. A nonisotopic assay for histone deacetylase activity. Nucleic Acids Res. 1999, 27, 2057-2058.
24. Nare, B.; Allocco, J. J.; Kuningas, R.; Galuska, S.; Myers, R. W.; Bednarek, M. A.; Schmatz, D. M. Development of a scintillation proximity assay for histone deacetylase using a biotinylated peptide derived from histone-H4. Anal. Biochem. 1999, 267, 390-396.
25. Richon, V. M.; Tolentino, T.; Breslow, R.; Rifkind, R. A.; Marks, P. A. The hydroxamic acid class of hybrid polar cytodifferentiation agents are potent inhibitors of histone deacetylaae activity. 90th Annual Meeting of the AACR, Apr 10-14, 1999; Abstr. #29.
26. Schmidt, K.; Gust, R.; Jung, M. Inhibitors of histone deacetylase suppress the growth of MCF-7 breast cancer cells. Arch. Pharm. Pharm. Med. Chem. 1999, in press.
27. Lechner, T.; Lusser, A.; Brosch, G.; Eberharter, A.; Goralik-Schramel, M.; Loidl, P. A comparative study of histone deacetylases of plant, fungal and vertebrate cells. Biochim. Biophys. Acta 1996, 1296, 181-188.
28. Richon, V. M.; Rifkind, R. A.; Marks, P. A. Differentiation of murine erythroleukemia cells (Friend Leukemia cells). In Cell Biology: A Laboratory Handbook; Academic Press Inc.: New York, 1994; pp 213-217.